Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 242 Observational 40 Expanded_access 1

Sponsor

Cancer Type

Thoracic 5 Sarcoma 4 Gastrointestinal 3 Tumor-Agnostic 2 Genitourinary 2 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Gynecologic 1 Dermatologic 1 CNS 1

Conditions

Neurofibromatoses 1 Neurofibroma, Plexiform 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × CNS × 30 days × Clear all

NCT05028166 2026-05-08

Individual Patient Compassionate Use of Mirdametinib

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Neurofibromatoses, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon ⚡